期刊文献+

天冬氨酸酶E.coli融合表达研究 被引量:4

Study on Fusion Expression of Aspartase in E.coli
下载PDF
导出
摘要 以大肠杆菌基因组DNA为模板,设计引物扩增得到天冬氨酸酶基因,将其重组于胞内融合表达型T载体中,重组质粒转化表达宿主大肠杆菌BL21(DE3)。SDS-PAGE分析表明,工程菌经IPTG诱导,表达大量表观分子量约75kD的融合蛋白。经试验,工程菌细胞具有较高的天冬氨酸酶活性,融合形式的酶最适温度37℃,最适pH8.5,融合伴侣DsbA的存在对酶活没有影响。 Aspartase gene was amplified and isolated from E.coli genomic DNA by PCR technology,then cloned into the intracellular fusion type T vector,and the recombinant plasmid was transformed into expression host E.coli BL21(DE3).The IPTG induced engineered strain was analyzed by SDS-PAGE,which showed a fusion protein was expressed with an apparent molecular weight of 75 kD.The engineered cells was approved to have a high aspartase activity,and the recombinant aspartase fusion protein exhibited optimal activity at 37℃ and pH8.5,while the DsbA fusion partner had no affect on the aspartase activity.
出处 《氨基酸和生物资源》 CAS 2012年第1期13-15,20,共4页 Amino Acids & Biotic Resources
关键词 天冬氨酸酶 融合蛋白 DSBA 表达 aspartase fusion protein DsbA expression
  • 相关文献

参考文献10

  • 1Yasuhisa Asano, Ikuo Kira, Kenzo Yokozeki. Altera- tion of substrate specificity of aspartase by directed evolution[J]. Biomolecular Engineering, 2005,22: 95 -101.
  • 2张今,张红缨,王晓平,陆军,杜文媛.天冬氨酸酶的研究与应用[J].自然科学进展(国家重点实验室通讯),1997,7(3):266-270. 被引量:5
  • 3郝大伟,裘娟萍.生物催化富马酸加氨合成天门冬氨酸的研究进展[J].氨基酸和生物资源,2008,30(2):39-43. 被引量:10
  • 4Shi W X, Dunbar J, Jayasekera M M K, et al. The structure of L-aspartate ammonia-lyase from Esche- richiacoli[J]. Biochemistry, 1997, 36:9136-9144.
  • 5Wang L J, Kong X D, Zhang H Y, et al. Enhance- ment of the activity of L-aspartase from Escherickia coli W by directed evolution[J]. Biochemical and Bio- physical Research Communications, 2000, 276: 346- 349.
  • 6林琳,张今.高活力天冬氨酸酶的分离提纯及性质[J].吉林大学自然科学学报,1999(2):75-78. 被引量:2
  • 7Paulsen J, Hustedt H. Extraction and Purification of Aspartase from Escherichia coli K12 [J]. Methods Enzymol, 1994, 228:590-599.
  • 8Shouldice S R, Heras g, Walden P M,et al. Structure and function of DsbA, a key bacterial oxidative folding catalyst[J]. Antioxidants - Redox Signaling, 2011, 14(9): 1729-1760.
  • 9Makrides S C. Strategies for achieving high-level ex- pression of genes in Escherichia coZi[J]. American So- ciety for Microbiology, 1996, 60(3): 512-538.
  • 10林陈水,黎小军,王平,梅建凤.人胸腺素α_1基因工程菌的构建与表达[J].浙江工业大学学报,2005,33(3):306-309. 被引量:5

二级参考文献43

  • 1张红缨,李正强,张今.ENZYMATIC GENERATION OF MUTANT LIBRARIES in vitro FOR RANDOM MUTAGENESIS OF THE ASPARTASE GENE[J].Chinese Science Bulletin,1992,37(7):598-601. 被引量:2
  • 2Zhang Hongying,Chin Sci Bull,1992年,37卷,7期,598页
  • 3周本正,层析技术及其应用,1992年,43页
  • 4张树政,酶制剂工业.下,1984年,741页
  • 5张龙翔,生化实验方法和技术,1981年
  • 6Low T L, Goldstein A. The chemistry and biology of thymosin Ⅰ : amino acid sequence of thymosin alpha 1 and polypeptide beta[J]. Biol. Chem, 1979,254(3): 987-995.
  • 7Michalewshy J, Gabriel I F, Winter D P,et al. Confirmation of the primary structure of thymosin alpha1 by microsequence analysis of limited acid and enzymatic hydrolysis fragments [J]. Int J Pept Protein Rcs,1983,21(1):93 99.
  • 8Amarapurkar D, Das H S. Thymosin alpha in the treatment of chronic hepatitis B: an uncontrolled open-label trial[J]. Indian J Gastroenterol,2002,21(2): 59-61.
  • 9Saruc M,Yuceyar H, Kucukmetin N, et al. Combination thymosin-alpha 1 and interferon-alpha 2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey[J]. Hepatogastroenterology, 2002,49 (45): 798-802.
  • 10Lau G K, Nanji A, Hou J, et al. Thymosin alpha 1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase[J]. Viral Hepat, 2002, 9(4):280-287.

共引文献18

同被引文献22

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部